Immumax Expands Global Access to the E-Tapper to Empower Natural Health Management from Home

HONG KONG, Sept. 18, 2026 (GLOBE NEWSWIRE) -- Immumax, a pioneer in alternative health and wellness solutions, has announced the international expansion of its online training and consultation services. Focused on promoting personal health management through the body's natural immune system, the company is now offering its specialized therapy and the e-Tapper device to a broader global community. This expansion aims to provide international clients with new options for self-health management, emphasizing natural and non-invasive methods.

Central to this expansion is the e-Tapper, an Electronic Micro-current Stimulation Device developed to support personal wellness. Often referred to as a "mobile therapist" by clients due to its portability, the e-Tapper enables individuals to manage their health from the comfort of their homes. The device is designed to be highly user-friendly and safe, operating purely as an external method without the use of drugs or injections. It is primarily utilized by clients seeking alternative ways to help manage conditions such as various types of pain, allergies and sleeping problems.

Immumax has been dedicated to promoting immunity effectiveness since the early 2000s, reflecting its core vision that the human immune system plays a critical role in overall health. To support its mission, the company has published "The Wonderful Immunity", a book compiling stories of individuals who have utilized this non-invasive method. The company's innovative approach has also been recognized internationally, receiving the Silver Award at the 2007 International Inventions Exhibition in Geneva and a Certificate of Achievement at the 2022 Smart Ageing Awards in Hong Kong.

"What put me on this natural wellness pursuit was sparked off by my mom's miraculous restoration of her finger function in a matter of a few weeks," said Judy Wong, Founder & CEO of Immumax. "She had long years of suffering from carpal tunnel syndrome with multiple injections of steroids and a surgery which ripped the function of her two fingers for two years, until I treated her with this simple hand therapy. Witnessing the great relief and joy of my mom, I became determined to embark on the mission of helping more people to experience the wonderful power of immunity through this method."

Wong continued, "I would also like to take this opportunity to mention and sincerely thank a medical doctor in the USA who, sharing the same vision, very kindly allowed us to take over his domain name, immumax.com, which we have been using since 2004. His kind act has greatly inspired and encouraged us to serve thousands of people in the last two decades."

Moving forward, Immumax remains dedicated to its founding mission: advocating for self-health management by leveraging the body's natural immune power. By making its online consultation services and therapy training available worldwide, the company aims to ensure that more individuals can take their health into their own hands. Those interested in learning more about the e-Tapper device, exploring international consultation options, or reading patient stories in the published book "The Wonderful Immunity" are encouraged to visit the Immumax website.

About Immumax
Established in 2004 in Hong Kong, Immumax provides innovative products and consultation services focused on immunity and personal health management. Advocating for self-health management through natural and external methods, the company empowers clients to take control of their wellness. With the advancement of digital technology, Immumax has expanded its offerings to provide online therapy training and consultations to an international audience.

Media Contact
Name: C Kam, Immumax International Co, Limited

Email: info@immumax.com

Phone: +852 35683511

Website: www.immumax.com

WhatsApp: +852 5938 4238

WeChat: wxid_tj4cjm9akbz622

Photos accompanying this announcement are available at 

https://www.globenewswire.com/NewsRoom/AttachmentNg/77c2ad05-43e4-4f4d-8bdc-c9f49c5383f3

https://www.globenewswire.com/NewsRoom/AttachmentNg/e22c9147-911b-481f-8bdc-02de054b074e

Immumax International Co, Limited

Immumax International Co, Limited

Immumax International Co, Limited

Immumax International Co, Limited